Share

April 10, 2018; 90 (15 Supplement) April 27, 2018

Antiseizure properties of cannabidiol (CBD) are attenuated in the absence of transient receptor potential vanilloid 1 (TRPV1) receptors (S53.004)

Benjamin J. Whalley, Royston A. Gray, Colin G. Stott, Nicholas A. Jones
First published April 9, 2018,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 90 no. 15 Supplement S53.004
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 9, 2018.
Copyright & Usage: 
© 2018

Author Disclosures

    1. Benjamin J. Whalley1,
    2. Royston A. Gray1,
    3. Colin G. Stott1 and
    4. Nicholas A. Jones1
  1. Benjamin J. Whalley1,
  2. Royston A. Gray1,
  3. Colin G. Stott1 and
  4. Nicholas A. Jones1
  1. 1GW Research Ltd Cambridge United Kingdom

Article usage

Article usage: April 2018 to April 2022

AbstractFullPdfSource
Apr 20186300Highwire
May 20182500Highwire
Jun 20181600Highwire
Jul 2018900Highwire
Aug 20181500Highwire
Sep 20181300Highwire
Oct 20182900Highwire
Nov 20185300Highwire
Dec 20181000Highwire
Jan 20191300Highwire
Feb 20194200Highwire
Mar 20193500Highwire
Apr 20194100Highwire
May 20192400Highwire
Jun 20195800Highwire
Jul 201921600Highwire
Aug 20194700Highwire
Sep 20195300Highwire
Oct 20196900Highwire
Nov 20196300Highwire
Dec 20195200Highwire
Jan 20208500Highwire
Feb 202013400Highwire
Mar 20207300Highwire
Apr 202010600Highwire
May 20209600Highwire
Jun 202011100Highwire
Jul 202010600Highwire
Aug 20206800Highwire
Sep 20207600Highwire
Oct 20207400Highwire
Nov 20207900Highwire
Dec 202013900Highwire
Jan 20218000Highwire
Feb 20216400Highwire
Mar 20214800Highwire
Apr 202113000Highwire
May 20219200Highwire
Jun 20217700Highwire
Jul 202110900Highwire
Aug 20218300Highwire
Sep 202117200Highwire
Oct 202121500Highwire
Nov 202118000Highwire
Dec 202111500Highwire
Jan 202210900Highwire
Feb 202211000Highwire
Mar 202210600Highwire
Apr 202210200Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me